Dexcom ONE+ Continuous Glucose Monitoring System

Dexcom ONE+ is a next-generation real-time Continuous Glucose Monitoring (CGM) system designed for people living with type 1 or type 2 diabetes. Developed as a more accessible and user-friendly version of Dexcom's advanced sensor technology, it eliminates the need for routine finger pricks by providing steady, automatic glucose readings sent directly to a smartphone or compatible receiver. This specific model is part of Dexcom's strategic move to simplify diabetes management across international markets.

The Dexcom brand was founded in San Diego, California, where its global headquarters remain today. As a pioneer in the medical technology sector, Dexcom has consistently focused on innovating glucose sensing solutions. The company maintains its independence as an American medical device giant, resisting acquisition by larger pharmaceutical conglomerates to focus exclusively on its proprietary sensor hardware and digital health platforms.

While the company's core research and high-tech manufacturing are rooted in the United States, Dexcom has expanded its production capabilities to meet global demand. This includes significant manufacturing facilities in Mesa, Arizona, as well as international operations in countries like Ireland and Mexico. The brand is managed globally through various regional subsidiaries to ensure local regulatory compliance and distribution logistics for healthcare providers and patients alike.